JPS61103449A - Artificial blood vessel having x-ray contrast property - Google Patents

Artificial blood vessel having x-ray contrast property

Info

Publication number
JPS61103449A
JPS61103449A JP59224059A JP22405984A JPS61103449A JP S61103449 A JPS61103449 A JP S61103449A JP 59224059 A JP59224059 A JP 59224059A JP 22405984 A JP22405984 A JP 22405984A JP S61103449 A JPS61103449 A JP S61103449A
Authority
JP
Japan
Prior art keywords
ray contrast
contrast agent
artificial blood
blood vessel
large number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59224059A
Other languages
Japanese (ja)
Inventor
八木橋 英男
博 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Gore Tex Inc
Original Assignee
Japan Gore Tex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Gore Tex Inc filed Critical Japan Gore Tex Inc
Priority to JP59224059A priority Critical patent/JPS61103449A/en
Publication of JPS61103449A publication Critical patent/JPS61103449A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、ポリテトラフロロエチレンC以下。[Detailed description of the invention] [Industrial application field] The present invention uses polytetrafluoroethylene C or less.

PTFEという)を用いたX線造影性を有する人工血管
に関するものである。
This invention relates to an artificial blood vessel using X-ray contrast properties (referred to as PTFE).

〔従来の技術〕[Conventional technology]

損傷した血管(動脈および静脈)を外科的補綴する材料
である人工血管としては、自家静脈、生物起源の材料お
よび合成材料が使用されているが、前二者には臨床的、
資源的に問題があるため、合成材料が多く用いられてい
る。合成材料の人工血管として現在主に使用されている
のは、ポリエステルあるいはポリテトラフロロエチレン
の糸ヲ製織あるいは編織したチューブおよび延伸多孔質
ポリテトラフロロエチレン(expaned PTFE
またはFiPTFB商品名GOre −’rex■)の
チューブである。
Artificial blood vessels, which are materials used to surgically repair damaged blood vessels (arteries and veins), include autologous veins, biogenic materials, and synthetic materials.
Due to resource issues, synthetic materials are often used. Currently, the main synthetic materials used as artificial blood vessels are tubes made from woven or knitted polyester or polytetrafluoroethylene threads, and expanded porous polytetrafluoroethylene (PTFE).
or FiPTFB (trade name: GOre-'rex■) tube.

特に、EPTFE人工血管は、その性能を表す尺度であ
る抗血栓性、開存率(移植した人工血管に血流が維持さ
れる割合)5組織への順応性、手術時の取扱性、柔軟性
などにおいて優れていることが、松本等の「Porou
s Po1ytetrafluoroethylene
の人工血管への応用」1人工臓器、第1巻、第7号〔昭
和り2年3月13日発行)以来、多ぐの医学文献に示さ
れている。EPTFE人工血管に関する発明としては、
特公昭5.2−907グ号および特公昭!3−3971
9号が知られている。
In particular, EPTFE artificial blood vessels have antithrombotic properties, which are measures of their performance, patency rate (the rate at which blood flow is maintained in the transplanted artificial blood vessels), adaptability to tissues, ease of handling during surgery, and flexibility. Matsumoto et al.'s “Porou
s Polytetrafluoroethylene
Since 1 Artificial Organs, Volume 1, No. 7 [Published March 13, 1929], it has been described in many medical literature. Inventions related to EPTFE artificial blood vessels include:
Tokuko Sho 5.2-907 Gu and Tokko Sho! 3-3971
No. 9 is known.

FiPT’F’に人工血管は、上記のように優れた性能
!持っているけれども、それ自体はX線透過性であるた
め、移植手術後にその位置を体外からX線写真によって
確認することはできない。しかし、移植後のEPTFE
人工血管の位置が、X線写3f+[よって容易IC確認
できれば、移植手術の成否についての一つの石力な情報
が得られることになり、1″)    外科学的に有意
義なことである。
FiPT'F' artificial blood vessels have excellent performance as mentioned above! However, because it is radiolucent, its position cannot be confirmed from outside the body by X-ray photography after the transplant surgery. However, EPTFE after implantation
If the position of the artificial blood vessel can be easily confirmed on an X-ray image 3F+ (IC), it will provide vital information regarding the success or failure of the transplant surgery, which is surgically significant.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

上記のような従来の人工血管の問題に鑑みて、X線造影
性!有し、しかも抗血栓性、開存率、組織との順応性、
非炎症性、手術時の取扱性、柔軟性の優れた人工血管t
つ(ることか当業界の課題となっていたのである。
In view of the above-mentioned problems with conventional artificial blood vessels, X-ray contrastability! In addition, it has antithrombotic properties, patency rate, compatibility with tissues,
Artificial blood vessel t that is non-inflammatory, easy to handle during surgery, and has excellent flexibility
This has become an issue in our industry.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者等は、上記の課題を解決すべ(種々検討した結
果、平均粒径10μm以下のX線造影剤微粉末、20〜
20重量係と多数の微小結節がフィブリルによって互い
に結合され、これらの間に多数の空隙が形成さη、た多
孔性微細構造を有するFTFB3o〜g0重量係とから
なり、かつX線造影剤の大部分が上記微小結節に含有さ
れた材料からなる人工血管、もしくはこの人工血管の内
側および/または外側に、多数の微小結節がフィブリル
によって互いに結合され、これらの間に多数の空隙が形
成された多孔性微細構造ン有す71JPTFK層を設け
Tこ人工血管が上記目的に叶うものである   1こと
を発見し、本発明!完成したのである。
The present inventors have solved the above-mentioned problem (as a result of various studies, X-ray contrast agent fine powder with an average particle size of 10 μm or less,
FTFB3 is composed of FTFB3o~g0G0 having a porous microstructure, and a large number of micronodules are connected to each other by fibrils, and a large number of voids are formed between them, and a large number of X-ray contrast agents. An artificial blood vessel whose portion is made of the material contained in the micronodules, or a porous pore in which a large number of micronodules are connected to each other by fibrils and a large number of voids are formed between them on the inside and/or outside of this artificial blood vessel. We have discovered that an artificial blood vessel with a 71JPTFK layer having a unique microstructure can meet the above objectives, and we have invented the invention! It was completed.

先ず、本発明の人工血管の製造f:yr要約すれば。First, the production f:yr of the artificial blood vessel of the present invention will be summarized.

(1)X線造影剤とPTFBとの組成物を液状潤滑剤と
混和してペースト状の混和物をつ(す、それをチューブ
状またはシート状に押し出して成形品とし、該成形品か
ら液状潤滑剤を除去しくまたは除去せずに)、高められ
た温度において延伸し、該延伸物を単独または適当に組
合せて管状に成形し。
(1) Mix a composition of an X-ray contrast agent and PTFB with a liquid lubricant to form a paste-like mixture, extrude it into a tube or sheet shape to make a molded product, and then (with or without removal of the lubricant) at elevated temperatures, and the drawn product, alone or in suitable combinations, is formed into a tubular shape.

熱処理または焼成して人工血管とするか、(2)【2〕
の場合と逆構成とするか、あるいは(4)  (21と
(3)を組合せて所望の人工血管とする。
Is it heat treated or fired to make an artificial blood vessel? (2) [2]
The desired artificial blood vessel can be obtained by reversing the configuration of (4) (21) and (3).

先ず、〔1〕の方法について詳しく説明するOX線造影
剤として、従来からこの目的に使用されている無機粉末
、例えば硫酸バリウム、酸化ビスマス、硝酸ビスマス、
炭酸ビスマス、ニッケル粉などの微粉末で、平均粒径が
108m以下、好適には3μm以下、特に1μm以下の
ものを用意する。平均粒径が10μm以上では9次の成
形工程での加工性が著しく阻害されるからである0こt
ムLdj−1Cp分    ゛ C厄Y二 ヨンに添加し、攪拌混合する0攪拌混合の過程で。
First, the method [1] will be explained in detail.As an OX-ray contrast agent, inorganic powders conventionally used for this purpose, such as barium sulfate, bismuth oxide, bismuth nitrate,
A fine powder such as bismuth carbonate or nickel powder with an average particle diameter of 108 m or less, preferably 3 μm or less, particularly 1 μm or less is prepared. This is because if the average particle size is 10 μm or more, the workability in the 9th molding process will be significantly inhibited.
In the process of stirring and mixing, add 1Cp to 1Cp and stir and mix.

PTFE微粒子が造影剤微粒子の周りに析出し、ゲル化
して沈#する。このゲル化までの過程を共凝析という。
PTFE microparticles precipitate around the contrast agent microparticles, gel, and precipitate. This process leading to gelation is called co-coagulation.

この共凝析の終りの過程で酸またはアルカリな少量添加
すると沈澱が促進される0沈澱が完了したら、上澄液!
傾斜し、得られるFTFBとX線造影剤との混和物を乾
燥する。この共凝析法によってはじめて、20重量%C
以下1%はすべて重量%Y表わす)以上のX線造影剤を
FTFB中に混合でき、そして次の成形工程を経ても外
観上大きな問題のない成形品が得られる0この混和物中
のX線造影剤の含量は、混和物の全重量の20〜20%
、好適にはグ0〜60%とする。20%以下では充分な
X線造影性能が得られず、また70%以上では成形性が
低下すると共に、X線造影剤が成形品から離脱する等の
問題が生ずるからである〇 上記のようにして得られた混和物は、慣用の一=二:ニ
ニムニWiJI’ a−IJ k−=シーニニニ―−二
一一一即ち、X線造影剤とPTFEとの混和物vi状温
潤滑剤例えばソルベントナフサ、ホワイトオイルなどの
液状炭化水素、石油エーテルなど)と約80ニス0の重
量比で混合し、その混合物から予備成形品をつ(す、該
予備成形品!ラム押出機!用いてチューブ状またはシー
ト状に押し出す。シート状の成形品は、ある程度の強度
を有するが、そのままでは、延伸工程に使用できないの
で、ロールニヨってその肉厚が約l/2〜/ / / 
OK す6ように圧延すると強度が高まる。こうして得
られたチューブ状またはシート状の成形品から、液状潤
滑剤を抽出または加熱揮散させることによって除去する
。なお、液状潤滑剤を除去しない成形品も次の延伸工程
に用いることができるが結果は良(ない。
At the end of this co-coagulation process, adding a small amount of acid or alkali will accelerate precipitation. 0 Once precipitation is complete, supernatant liquid!
Decant and dry the resulting mixture of FTFB and X-ray contrast agent. By this co-coagulation method, 20% by weight C
The X-ray contrast agent in the following 1% (all percentages by weight) can be mixed into FTFB, and a molded product with no major problems in appearance can be obtained even after the next molding process. The content of contrast agent is 20-20% of the total weight of the mixture
, preferably 0 to 60%. If it is less than 20%, sufficient X-ray contrast performance cannot be obtained, and if it is more than 70%, moldability decreases and problems such as the X-ray contrast agent separating from the molded product occur. The resulting mixture is a mixture of the conventional 1=2:Ninimuni WiJI' a-IJ k-=Seenininny--2111, i.e., a mixture of an X-ray contrast agent and PTFE. , liquid hydrocarbons such as white oil, petroleum ether, etc.) in a weight ratio of about 80 parts to 0 parts, and from the mixture a preform is produced (the preform is made into a tubular or It is extruded into a sheet.Although the sheet-shaped molded product has a certain degree of strength, it cannot be used in the stretching process as it is, so the thickness of the sheet-shaped product is about 1/2 ~ / / /
OK When rolled in this way, the strength increases. The liquid lubricant is removed from the tube-shaped or sheet-shaped molded product thus obtained by extraction or heating and volatilization. Note that molded products without removing the liquid lubricant can also be used in the next stretching process, but the results are not good.

上記のようにして得られたチューブ状またはシート状の
X線造影剤を含むPTFE成形品をグo。
The tube-shaped or sheet-shaped PTFE molded product containing the X-ray contrast agent obtained as described above is used.

b、    C以下の温度、好適にはFTFBの融点以
下の温1wに加熱しながら、少な(とも一方向に延伸す
る。
b. While heating to a temperature below C, preferably at a temperature below the melting point of FTFB, the film is stretched a little (both in one direction).

延伸倍率は1.2〜−〇倍程度とする。この延伸によっ
て材料の断面積はあまり減少せず延伸方向の寸法が大き
(なるので、結果物は必然的に空隙を生じ、多孔質化す
る。延伸時の温度がPTFEの融点以上である場合には
、延伸された成形品は。
The stretching ratio is approximately 1.2 to -0 times. This stretching does not significantly reduce the cross-sectional area of the material, but increases its dimension in the stretching direction, so the resulting product inevitably has voids and becomes porous. is a stretched molded product.

程度は高ぐないけれども焼成されるが、PTFEの融点
以下の場合には未焼成である。こうして得られろ不完全
焼成または未焼成の延伸PTFEチューブまたはシート
は延伸状態を維持して41 PTFEの融点以上の温度
に加熱して更に焼成度を高めると寸法安定性および強度
が向上する。焼成度は、焼成温度と時間に比例するので
、目的に応じて、即ち、それ自体が完成品である場合に
完全に焼成し。
Although it is fired to a lesser extent, it is unfired if the temperature is below the melting point of PTFE. The incompletely fired or unfired expanded PTFE tube or sheet thus obtained is maintained in the stretched state and heated to a temperature above the melting point of 41 PTFE to further increase the degree of firing, resulting in improved dimensional stability and strength. The degree of firing is proportional to the firing temperature and time, so depending on the purpose, that is, when the product itself is a finished product, it can be completely fired.

中間体〔更に加工を施されるもの〕の場合は、加工し易
い程j¥に焼成する。こうして得られるチューブの肉厚
は約0.””’−’2mm、外径は最大30mm程度の
範囲で調節でき、またシートの肉厚は約″−″″〜4″
”・幅は厚−J[4J17″が′・5″   1程度ま
での範囲で調節できる。
In the case of an intermediate product (to be further processed), it is fired to the extent that it is easier to process. The wall thickness of the tube thus obtained is approximately 0. ""-'2mm, the outer diameter can be adjusted within a maximum range of about 30mm, and the sheet thickness is approximately "-""~4"
``・Width can be adjusted within the range of thickness -J[4J17'' to about 1''/5''.

このようにして延伸されたX線造影剤を含有する連続気
孔性多孔質PTFEは、多数の微小結節が多数のフィブ
リル〔微細繊維)によって互いに結合され、微小結節と
フィブリルとの間に連続性の空隙〔微細気孔)が形成さ
れた多孔性微細構造!もっている。意外なことに、X線
造影剤は、その微小結節の部分に殆ど含有され、そして
フィブリル部にはX線造影剤は殆ど含有されていない。
The open-pore porous PTFE containing the X-ray contrast agent stretched in this way has a large number of micronodules connected to each other by a large number of fibrils, and there is a continuity between the micronodules and the fibrils. Porous microstructure with voids (micropores) formed! I have it. Surprisingly, most of the X-ray contrast agent is contained in the micronodule portion, and almost no X-ray contrast agent is contained in the fibril portion.

そのため、この材料の機械的特性は、X線造影剤を含有
しない連続気孔性多孔質PTFEとあまり変わらない。
Therefore, the mechanical properties of this material are not significantly different from open-cell, porous PTFE that does not contain an X-ray contrast agent.

例えば、フィブリル長はQ、j〜300μ、空孔率2j
〜90%、引張り強さはX線造影剤の含量が増加する程
弱(なるが約10%減止りであり、そして柔軟性、可撓
性、伸縮性1弾性回復力は豊かである。
For example, the fibril length is Q, j ~ 300μ, the porosity is 2j
~90%, the tensile strength is weaker as the content of X-ray contrast agent increases (but only decreases by about 10%), and the flexibility, flexibility, elasticity and elastic recovery are rich.

上記の焼成されたX線造影剤を含有する延伸多孔質PT
FFi(以下、延伸多孔質PTFEをBPTFEという
)チューブは、そのまま人工血管として使用できるが、
縫合針による引き裂けや血圧による拡張に対する耐久性
を高める必要がある場合には、上記のようにして見られ
た未焼成ないし不完全焼成のX線造影剤を含有するEP
TFEチューブの周囲に同様にして得られた未焼成ない
し不完全焼成EPTFFliテープを巻付は一体化させ
るか、あるいは上記のようにしてえられたX線造影剤を
含N−fる未焼成ないし不完全焼成のEPTFEシート
をスリットしたテープを所望の外径の金属棒の上に均一
に巻き付け、固定してから、PTFlnの融点以上の温
度に加熱して焼成一体化させ、その後、金属棒を引抜(
ことによって製造する。
Stretched porous PT containing the above calcined X-ray contrast agent
FFi (hereinafter expanded porous PTFE is referred to as BPTFE) tube can be used as it is as an artificial blood vessel, but
If it is necessary to increase the durability against tearing caused by suture needles or dilatation caused by blood pressure, EP containing an unfired or incompletely fired X-ray contrast agent as seen above may be used.
An unfired or incompletely fired EPTFFli tape obtained in the same manner is wrapped around the TFE tube, or an unfired or incompletely fired EPTF Li tape containing an X-ray contrast agent obtained as described above is wrapped around the TFE tube. A tape made by slitting an incompletely fired EPTFE sheet is evenly wrapped around a metal rod of the desired outer diameter and fixed, then heated to a temperature higher than the melting point of PTFln to integrate it, and then the metal rod is Pulling out (
manufactured by

また、縫合針による引き裂け、血圧による拡張[対fる
耐久性や抗血栓性!高めたり1組織との付着性馨少な(
したり、X線造影剤の離脱の可能性を無(したい場合に
は、上記のX線造影剤を含むEPTFEチューブの内側
および/または外側に、多数の微小結節がフィブリルに
よって互に結合され、これらの間に多数の空隙が形成さ
れた多孔性微細構造を有するX線造影剤を含有しないB
PTFE層を設けるとよい。
In addition, it is durable and anti-thrombotic! Increase or decrease adhesion with one tissue (
or eliminate the possibility of detachment of the X-ray contrast agent, a large number of micronodules are connected to each other by fibrils on the inside and/or outside of the EPTFE tube containing the X-ray contrast agent, B, which does not contain an X-ray contrast agent, has a porous microstructure with many voids formed between them
It is preferable to provide a PTFE layer.

ここで使用される上記の多孔性微細構造を有するX線造
影剤を含有しないEPTFKのシートおよびチューブを
製造する方法は1例えば特公昭yg−タグ66グ号公報
、特開昭グロー7.2gグ号公報、あるいは特開昭30
−22gg1号公報などに記載された方法に準じて行な
われる。即ち、PTFE粉末(またはPTFEディスパ
ージョン凝m物’)[液状潤滑剤(例えばソルベントナ
フサ、ホワイトオイルなどの炭化水素油1石油エーテル
等)を添加混合〔混合比PTFE :液状潤滑剤=80
:、2o)し、その混合物から予備成形物tつ(す、該
予備成形物をラム押出機を用いてシート状またはチュー
ブ状に押出し、シート状物は必要に応じて圧延して成形
物tつ(る0この成形物から液状潤滑剤!除去し〔除去
しな(ても良いが、結果的に良(ない)、次にこれをグ
OOC以下において少な(とも一方向に7,2〜.20
倍程度延伸する。次に。
The method for manufacturing EPTFK sheets and tubes that do not contain an X-ray contrast agent and have the above-mentioned porous microstructure used here is described in 1, for example, Japanese Patent Publication No. Sho YG Tag No. 66, Japanese Patent Publication No. Sho Glow 7.2 G. Publication No. 1, or Japanese Unexamined Patent Application Publication No. 1963
It is carried out according to the method described in -22gg No. 1 and the like. That is, PTFE powder (or PTFE dispersion agglomerate') is mixed with the addition of a liquid lubricant (for example, solvent naphtha, hydrocarbon oil such as white oil, 1 petroleum ether, etc.) [Mixing ratio PTFE:liquid lubricant=80
:, 2o) and extrude the preform from the mixture into a sheet or tube using a ram extruder, and roll the sheet as necessary to form a molded product. Remove the liquid lubricant from this molded product (you may not remove it, but the result is not good). .20
Stretch it approximately twice as much. next.

該延伸物を延伸状態において悔恭巾牟融点以」二または
それより多少低い温度、好ましくはス00〜3907:
:で加熱\スルζ上蒼)とう台才ξ11云♂q皆7)o
′1%、 結合され、これらの間に多数の空隙が形成された多孔性
微細構造含有し、柔軟性、可撓性、耐熱性、耐薬品性、
撥水性、非接着性、滑り性、伸縮性、弾性回復力などに
富むものであって1通常、肉厚0 、03〜3−6mm
、特にD −3−〜2 、 DHlm。
In the stretched state, the stretched product is heated at a temperature of 2'2" or slightly lower than the melting point of the pentagonal cloth, preferably from 00 to 3907:
:Heated with \suru ζ上ao)Todai Sai ξ11云♂qEveryone 7)o
'1%, contains a porous microstructure with many voids formed between them, and has flexibility, flexibility, heat resistance, chemical resistance,
It is rich in water repellency, non-adhesiveness, slipperiness, stretchability, elastic recovery power, etc., and usually has a wall thickness of 0.03 to 3-6 mm.
, especially D-3-~2, DHlm.

気孔率30〜9j%、特に60〜90%、平均孔径0.
O1〜コ0μ、特にl〜jμ、ガーレーナンバー(6,
グーt cntの断面’f’2.7mmHgの圧力下に
/ OD QQの空気が透過するのに要する時間)0+
O1〜5000秒、水漏れ圧力O+ノ〜1−sKy/c
mである0これらの諸性質は、製造条件を調節すること
により、広範囲に変え得るので、目的に合った材料を得
ることができろ。
Porosity: 30-9j%, especially 60-90%, average pore size: 0.
O1~ko0μ, especially l~jμ, Gurley number (6,
Cross section of goo t cnt 'f' Under a pressure of 2.7 mmHg / OD QQ time required for air to permeate) 0+
O1~5000 seconds, water leak pressure O+~1-sKy/c
m is 0 These properties can be varied over a wide range by adjusting the manufacturing conditions, so it is possible to obtain a material suitable for the purpose.

また、(2〕の方法により、上記したX線造影剤を含M
−する未焼成ないし不完全焼成EPTFEチューブの外
側に、上記のX線造影剤を含有しないEPTFEiを設
けるには、上記チューブを金属棒に通し、その上に上記
のX線造影剤を含有しない   IEPTFEのテープ
を均一に巻付け、固定して、 PT’FEの融点以上の
温度に加熱し、焼成一体化させ、金属棒を引き抜(こと
により実現できる。
In addition, by the method (2), M
- To provide the above-mentioned X-ray contrast agent-free EPTFE on the outside of an unfired or incompletely-fired EPTFE tube, the tube is passed through a metal rod and the above-mentioned X-ray contrast agent-free IEPTFE is placed on the outside of the unfired or incompletely fired EPTFE tube. This can be achieved by uniformly wrapping and fixing the tape, heating it to a temperature higher than the melting point of PT'FE, baking it into one piece, and pulling out the metal rod.

また、(3)の方法により、上記のX線造影剤を含有し
ないEPTFE層を上記したX線造影剤を含有するEP
TFEチューブの内側に設けるには、金属棒に上記のX
線造影剤!含有しない未焼成ないし不完全焼成EPTF
Eチューブtかぶせるか、あるいは同種のEPTFEテ
ープ!均一に巻付け、その上に上記したX線造影剤ン含
有する未焼成ないし不完全焼成のEPTFEテープ!均
一に重なった状態あるいは間隔を置いた螺旋状またはリ
ング状に巻付け、固定し、全体VPTFEの融点以上の
温度に加熱して一体化させ、その後、金属棒を引き抜け
ばよい。
In addition, by the method (3), the EPTFE layer not containing the above-mentioned X-ray contrast agent is replaced with the EPTFE layer containing the above-mentioned X-ray contrast agent.
To install it inside the TFE tube, attach the above X to the metal rod.
Linear contrast agent! Contains no unfired or incompletely fired EPTF
Cover with E-tube or similar EPTFE tape! Unfired or incompletely fired EPTFE tape wrapped uniformly and containing the above-mentioned X-ray contrast agent on top! The metal rod may be wound and fixed in a uniform overlapping state or in a spiral or ring shape with intervals, heated to a temperature higher than the melting point of the whole VPTFE to integrate, and then the metal rod is pulled out.

また、〔4〕の方法により、上記のX線造影剤を含有し
ないEPTFE層を上記したX線造影剤を含有するFi
PTFEチューブの内側および外側に設けるには、〔2
)および(3)の方法を適宜組合せればよい。
In addition, by the method [4], the EPTFE layer not containing the above-mentioned X-ray contrast agent is replaced with the above-mentioned EPTFE layer containing the above-mentioned X-ray contrast agent.
For installation on the inside and outside of the PTFE tube, [2
) and (3) may be combined as appropriate.

なお、上記したX線造影剤を含有するFiPTFEチュ
ーブに上記のX線造影剤を含有しないBPTFEj層を
設置するに当っては、上記(2)〜(4)の方法に限ら
ず、テープ!交互に巻(あるいは3層以上に構成するな
どの変更を人工血管としての要求条件1例えばX線造影
性の強さ、柔軟性、耐拡張性などに応じて適宜実施でき
ることは、勿論である。
Note that when installing the BPTFEj layer that does not contain the above-mentioned X-ray contrast agent on the FiPTFE tube that contains the above-mentioned X-ray contrast agent, it is not limited to the methods (2) to (4) above, and tape! Of course, changes such as alternating winding (or configuring three or more layers) can be made as appropriate depending on requirements 1 for the artificial blood vessel, such as strong X-ray contrast, flexibility, and expansion resistance.

〔実施例〕〔Example〕

以下、実施例によって本発明を更に詳しく説明するが1
本発明は、これらにより限定されるものではない。
Hereinafter, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these.

実施例 1 平均粒径り、7μmの硫酸バリウム(キシダ化学製)グ
Kyを水コj!に分散させた後、FTFEディスパージ
ョンを固形分6にノとなる量を添加し攪拌混合して硫酸
バリウムとFTPKを共凝析させ、凝析完了後、上澄み
液Y流し出し、得られた凝析物k1.2oCでλ日間、
加熱乾燥して硫酸バリウムグO%、PTFE A o%
のか粒状混合粉末を得た。
Example 1 Barium sulfate (manufactured by Kishida Chemical Co., Ltd.) with an average particle size of 7 μm was added to water. After dispersing the FTFE dispersion in an amount equal to the solid content 6, the barium sulfate and FTPK are co-coagulated by stirring and mixing. After the coagulation is completed, the supernatant liquid Y is poured out and the resulting precipitate is Precipitate k1.2oC for λ days,
Heat and dry to obtain barium sulfate O%, PTFE Ao%
A granular mixed powder was obtained.

この混合粉末100重量部に対して25重量部の石油ナ
フサを混合し1通常のPTFBペースト押出成形法と同
様にして、内径グmm 、肉厚1.9mmのチューブ状
に押出し、加熱により石油ナフサを除去させた後、長手
方向に1.1倍に延伸し、引き続いて延伸状態を保持し
たまま370Cに加熱して内径3 + g mm、肉厚
0−9mmの、X線造影剤tグ0重量係含む人工血管を
得た。
100 parts by weight of this mixed powder was mixed with 25 parts by weight of petroleum naphtha, extruded into a tube shape with an inner diameter of mm and a wall thickness of 1.9 mm in the same manner as the usual PTFB paste extrusion molding method, and heated to form a tube containing petroleum naphtha. After removing the An artificial blood vessel containing a weight factor was obtained.

こうして得られた人工血管は、柔軟で/ 6R−fで湾
曲させても潰れ、皺の発生は無かった。また。
The thus obtained artificial blood vessel was flexible and did not collapse even when curved at 6R-f, and no wrinkles were generated. Also.

この人工血管y、−X線写真撮影したところ灰色に写っ
ておりX線造影性が確認できた〇 実施例 2 平均粒径0.7μmの硫酸バリウム(キシダ化学製)グ
眩を水2j、I!/に分散させた後、PTFEディスパ
ージョンを固形分A Kyとなる量を添加し攪拌混合し
て硫酸バリウムとPTFE”l共凝析させ、凝析完了後
、上澄み液を流し出し、得られた凝析物ン加熱乾燥して
硫酸バリウムグ0%、P T F E 60係の乾燥混
合粉末を得た。
When an X-ray photograph of this artificial blood vessel y was taken, it appeared gray and the X-ray contrast property was confirmed. ! / After dispersing the PTFE dispersion in an amount with a solid content of A Ky, the PTFE dispersion was stirred and mixed to co-coagulate barium sulfate and PTFE. The coagulum was dried by heating to obtain a dry mixed powder containing 0% barium sulfate and PTFE 60.

この混合粉末100重量部に対して25重量部ゝ゛  
 へ石油ナフサを混合し5通常−FTFB<−、X )
押出成形法により、厚さ100μm、幅’20mmのシ
ートを得た0このシートを更に、;iso’c加熱下に
長手方向にl、9倍に延伸することにより、空隙率92
%の多孔性微細構造を有するシートを得た。このシート
より幅20mmのチー1フ作成した0 これとは別に内径g mm、肉厚/mmの特開昭4tA
−72gグ号公報に記載の方法で得た多数の微小結節が
フィブリル(微細繊維)によって互いに結合された多孔
性徴al 、+lI造を有するEPTFEチューブを用
意し、このチューブに、外径30gmmのステンレス製
芯を挿入した後、上記硫酸バリウム入りのテープを巻回
(3ラツプ)シ、約35jCで約10分間加熱した後、
ステンレス製芯を取り除いて造影可能な人工血管を得た
25 parts by weight per 100 parts by weight of this mixed powder
Mix petroleum naphtha to 5 normal -FTFB<-,X)
A sheet with a thickness of 100 μm and a width of 20 mm was obtained by extrusion molding. This sheet was further stretched 9 times in the longitudinal direction under ISO'C heating to obtain a porosity of 92.
% of the porous microstructure was obtained. From this sheet, I made a chief with a width of 20 mm.In addition to this, I made a sheet with an inner diameter of g mm and a wall thickness of 4 mm.
An EPTFE tube having a porous structure in which a large number of micronodules obtained by the method described in Publication No. After inserting the core, the tape containing barium sulfate was wound (3 wraps) and heated at about 35JC for about 10 minutes.
The stainless steel core was removed to obtain a contrast-enabled artificial blood vessel.

これをX線写真撮影したところチューブが灰色から黒白
に写っており、造影効果が確認された〇実施例 3 ’jldtif!l:III″l ’)a ICL、”
−’ja e ′” ’J ’)””゛   1PTF
EA6%から成り、幅=2mm、空隙率35%、厚さ0
.3mmのテープを作成した。
When an X-ray photograph was taken of this, the tube appeared from gray to black and white, confirming the contrast effect. Example 3 'jldtif! l:III″l ')a ICL,”
-'ja e ′"'J')""゛ 1PTF
Made of EA6%, width = 2mm, porosity 35%, thickness 0
.. A 3mm tape was made.

このテープを実施例2に記載したと同様のiiEPTF
Bチューブ上に1cmのピッチを置いて螺旋巻し、さら
に特開昭411.−72g¥号公報に記載の方法で得た
多孔性微細構造!肩するPTFEシートより得たテープ
で肉厚160μm1幅2グ、jmmのテープを巻回C2
ラップ)した。次に、約35jCで10分間加熱後、実
施例2に記載したと同様にステンレス製芯体を取り除い
て造影可能人工血管&゛得た。これをX線写真撮影した
ところ、チューブ部に螺旋状の黒線が写り、造影効果が
確認できた0 実施例 4 実施例1と同様にして硫酸バリウム23%1PTFE7
7%の混和物を調製し、乾燥して、混合粉末を得た。こ
の混合粉末100重量部に対して20重量部の石油ナフ
サを混合し、ペースト押出法により内径smm、肉厚/
 mmのチューブY成形した。この成形物から加熱によ
り石油ナフサを除去した後、加熱下(ujOC)に2倍
延伸してEPTFEチューブを作成した。
This tape was prepared using iiEPTF similar to that described in Example 2.
It is spirally wound on the B tube with a pitch of 1 cm, and then JP-A No. 411. Porous microstructure obtained by the method described in -72g¥ publication! Wrap a tape obtained from a PTFE sheet with a wall thickness of 160 μm, a width of 2 g, and a length of jmm C2.
rap). Next, after heating at about 35 °C for 10 minutes, the stainless steel core was removed in the same manner as described in Example 2 to obtain a contrast-enabled artificial blood vessel. When this was taken on an X-ray, a spiral black line was seen on the tube part, and the contrast effect was confirmed.0 Example 4 Same as Example 1, barium sulfate 23% 1PTFE7
A 7% blend was prepared and dried to obtain a mixed powder. 20 parts by weight of petroleum naphtha was mixed with 100 parts by weight of this mixed powder, and the inner diameter smm, wall thickness /
A Y mm tube was formed. After removing petroleum naphtha from this molded product by heating, it was stretched twice under heat (ujOC) to create an EPTFE tube.

このチューブにg、7mm径のステンレス製芯体を挿入
した後、実施例3で使用したのと同じ肉厚ljfDlt
m、幅2グーsmmのテープを巻回(2ラツプ)し、3
AoC,/17分間加熱した後、芯体ン取り除いて人工
血管を作成した。
After inserting g, a stainless steel core with a diameter of 7 mm into this tube, the same wall thickness ljfDlt as used in Example 3
m, wrap a tape with a width of 2 smm (2 wraps), and
After heating for AoC,/17 minutes, the core was removed to create an artificial blood vessel.

これをX線撮影したところチューブが灰色に写っていた
When this was taken on an X-ray, the tube appeared gray.

〔発明の効果〕〔Effect of the invention〕

本発明Lf1X線造影性を石する人工血管は、その主要
部であるX線造影剤を含む連続気孔性多孔質PTFEが
、多数の微小結節とそれt3次元的に互いに連結するフ
ィブリルとの間に多数の空隙が形成された微細構造を有
し、X線造影剤は、その大部分が微小結節部分に含まれ
、フィブリル部には殆ど含まれていないため、引張強度
は、X線造影剤Z含まない延伸FTFBと同程度に高(
、柔軟性。
The Lf1 artificial blood vessel of the present invention with high X-ray contrast properties has a continuous porous PTFE containing an X-ray contrast agent, which is the main part, between a large number of micronodules and fibrils that are three-dimensionally connected to each other. The tensile strength of the X-ray contrast agent Z As high as the stretched FTFB without (
, flexibility.

伸縮性が有り1手術時の取扱性も優れている。また上記
の微細構造は、移植後に1体組織の人工血管壁内への生
長が可能であり、内壁面上への仮性内膜の形成が良好で
、抗血栓性、開存率も高い。
It has elasticity and is easy to handle during surgery. Furthermore, the above-mentioned microstructure allows a single tissue to grow into the wall of the artificial blood vessel after transplantation, has good formation of pseudointima on the inner wall surface, has antithrombotic properties, and has a high patency rate.

X線造影性についてみれば、造影性の強弱は、X線造影
剤の含量あるいは造影剤を含む層の厚さを調節すること
によって所望の程度に変更でき、まり場合によっては、
螺旋状あるいはバンド状に設けることもできる。さらに
、本発明の人工血管は、人工血管壁を層状に、特にフィ
ブリルの方向が交叉するように形成することができ、そ
うすることにより、縫合針、縫合糸による穴、亀裂を防
ぎ。
Regarding X-ray contrast properties, the strength of contrast properties can be changed to a desired degree by adjusting the content of the X-ray contrast agent or the thickness of the layer containing the contrast agent.
It can also be provided in a spiral or band shape. Further, in the artificial blood vessel of the present invention, the artificial blood vessel wall can be formed in layers, particularly in such a manner that the fibrils have crossed directions, thereby preventing holes and cracks caused by suture needles and suture threads.

また血圧による拡張に対する耐久性が74られる。Also, the durability against expansion due to blood pressure is 74%.

Claims (2)

【特許請求の範囲】[Claims] (1)平均粒径10μm以下のX線造影剤微粉末20〜
70重量%と多数の微小結節がフィブリルによつて互い
に結合され、これらの間に多数の空隙が形成された多孔
性微細構造を有するポリテトラフロロエチレン30〜8
0重量%とからなり、かつX線造影剤の大部分が上記微
小結節に含有されることを特徴とするX線造影性を有す
る人工血管。
(1) X-ray contrast agent fine powder with an average particle size of 10 μm or less 20~
70% by weight polytetrafluoroethylene 30-8, which has a porous microstructure in which a large number of micronodules are bonded to each other by fibrils and a large number of voids are formed between them.
0% by weight, and most of the X-ray contrast agent is contained in the micronodules.
(2)平均粒径10μm以下のX線造影剤微粉末20〜
70重量%と多数の微小結節がフィブリルによつて互い
に結合され、これらの間に多数の空隙が形成された多孔
性微細構造を有するポリテトラフロロエチレン30〜8
0重量%とからなり、かつX線造影剤の大部分が上記微
小結節に含有されるX線造影性を有する可撓性チューブ
の内側および/または外側に、多数の微小結節がフィブ
リルによつて互いに結合され、これらの間に多数の空隙
が形成された多孔性微細構造を有するポリテトラフロロ
エチレン層を設けたことを特徴とするX線造影性を有す
る人工血管。
(2) X-ray contrast agent fine powder with an average particle size of 10 μm or less 20~
70% by weight polytetrafluoroethylene 30-8, which has a porous microstructure in which a large number of micronodules are bonded to each other by fibrils and a large number of voids are formed between them.
A large number of micronodules are formed by fibrils on the inside and/or outside of the flexible tube with X-ray contrast properties, which consists of 0% by weight and most of the X-ray contrast agent is contained in the micronodules. An artificial blood vessel having X-ray contrast characteristics, characterized in that polytetrafluoroethylene layers are bonded to each other and have a porous microstructure in which a large number of voids are formed between the polytetrafluoroethylene layers.
JP59224059A 1984-10-26 1984-10-26 Artificial blood vessel having x-ray contrast property Pending JPS61103449A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59224059A JPS61103449A (en) 1984-10-26 1984-10-26 Artificial blood vessel having x-ray contrast property

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59224059A JPS61103449A (en) 1984-10-26 1984-10-26 Artificial blood vessel having x-ray contrast property

Publications (1)

Publication Number Publication Date
JPS61103449A true JPS61103449A (en) 1986-05-21

Family

ID=16807927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59224059A Pending JPS61103449A (en) 1984-10-26 1984-10-26 Artificial blood vessel having x-ray contrast property

Country Status (1)

Country Link
JP (1) JPS61103449A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019084309A (en) * 2017-11-10 2019-06-06 教生 毛利 Artificial blood vessel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019084309A (en) * 2017-11-10 2019-06-06 教生 毛利 Artificial blood vessel

Similar Documents

Publication Publication Date Title
CA1147109A (en) Porous structure of polytetrafluoroethylene and process for production thereof
US4713070A (en) Porous structure of polytetrafluoroethylene and process for production thereof
CA1143105A (en) Tubular organic prosthesis and process for production thereof
JPS6341544A (en) Porous highly expansible fluoropolymers and production thereof
US5980799A (en) Methods of making controlled porosity expanded polytetrafluoroethylene products and fabrication
DE69624380T2 (en) RADIAL REINFORCED Vascular TRANSPLANT MADE OF POLYTETRAFLUORETHYLENE
JP2007014803A (en) Tape-reinforced blood vessel implant piece with external reinforcement and its manufacturing method
US20070152367A1 (en) Eptfe process and product for medical applications
JPS6315904B2 (en)
GB2033234A (en) Tubular organic prosthesis and a process for the production thereof
JPH10505266A (en) Asymmetric porous polytetrafluoroethylene molded article and method for producing the same
US4647416A (en) Method of preparing a vascular graft prosthesis
EP0232543A2 (en) Tubular internal organ prosthetic material
JPS63226361A (en) Porous and flexible radially expanded fluoropolymers and production thereof
US4596577A (en) Napped fluororesin materials having continuous pores, and a method of manufacturing the same
JP2881939B2 (en) Surgical suture and method of manufacturing the same
JPS62500598A (en) Ultra-high molecular weight polyethylene products including vascular prostheses and methods of manufacturing the same and use of the pseudo↓-gel state
WO2003093356A1 (en) Stretched polytetrafluoroethylene moldings and process for production thereof
JP2970320B2 (en) Artificial blood vessel
EP0057590A2 (en) Napped fluororesin material having continuous pores, and a method of manufacturing the same
JPH0585189B2 (en)
JPS647856B2 (en)
JPH06189984A (en) Artificial blood vessel and method for producing the same
JPS62152467A (en) Method for manufacturing tubular organ prosthesis material
JPH0547219B2 (en)